Loading...
Upcoming Conferences: Alumis Inc. will participate in several investor conferences, including the Cantor Global Healthcare Conference on September 3, Wells Fargo Healthcare Conference on September 5, and the Morgan Stanley Global Healthcare Conference on September 8, among others. Each event will feature fireside chats or presentations at specific times.
Webcast Access: Live webcasts of these events will be available on the "Events" page of the Alumis website, with replays archived for 90 days.
Company Overview: Alumis is a late-stage biopharma company focused on developing targeted therapies for immune-mediated diseases. The company utilizes a proprietary data analytics platform to enhance patient health outcomes.
Pipeline Development: The company is advancing a pipeline that includes envudeucitinib for systemic immune-mediated disorders, A-005 for neuroinflammatory diseases, and lonigutamab for thyroid eye disease, along with several preclinical programs.
